CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 513610-513993 3 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1043 | 0-383 | Sentence | denotes | ELND002 is a potent inhibitor of a4 integrin-mediated human leukocyte adhesion in vitro Garrido Caroline, Mao Jennifer, Xu Yi-Zheng, Nguyen Van, Yednock Ted, Bard Frédérique Elan Pharmaceuticals, South San Francisco, United States ELND002 is a potent and selective pegylated small molecule alpha-4 integrin inhibitor currently being evaluated for the treatment of multiple sclerosis. |